Call for Abstract
Scientific Program
Acadamia
- Case Western Reserve University School of Medicine, USA
- University of Texas, School of Medicine at Houston, USA
- University of California, Los Angeles, USA
- UCLA Schools of Medicine and Public Health, USA
- Tufts University, USA
- University of Pittsburgh School of Medicine, USA
- UBC Center of Reproductive Health, Canada
- MD Anderson Cancer Center, USA
- University of Birmingham, UK
- UT Southwestern Medical Center, USA
- Nanyang Technological University, Singapore
- Institute of Hematology and Blood Transfusion, Czech Republic
- University of Manchester, UK
- National Research Centre, Egypt
- Minia University, Egypt
- Academy of Ecology, Russia
- Mansoura University, Egypt
- Chutro Clinic in Cordoba, Argentina
- University of Sharjah, UAE
- University of KwaZulu Natal, South Africa
- Journal of Clinical & Cellular Immunology
- Immunome Research
- Journal of Allergy & Therapy
- The International Journal of Apitherapy
Business
- Vaccinogen Inc.,USA
- Perkin Elmer, USA
- Chutro Clinic in Cordoba, Argentina
- Baylor Institute for Immunology Research, USA
- Amerimmune Immunology Diagnostic Laboratory, USA
- VaxDome LLC & Vaxin Inc., USA
4th International Conference and Exhibition on Immunology, will be organized around the theme “From Basic Immune Understanding to latest Immunology Breakthroughs ”
Immunology Summit-2015 is comprised of 38 tracks and 0 sessions designed to offer comprehensive sessions that address current issues in Immunology Summit-2015.
Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.
Register now for the conference by choosing an appropriate package suitable to you.
This exclusive session, deals with the presentations of research areas in the areas like Regulation of T-cell activation during immune responses to autoantigens in diabetes in other autoimmune diseases. Modulation of T cell activation have centered on understanding and altering the positive signals delivered by the antigen-specific T cell receptor and secondary, so-called co-stimulatory signals, or engaging the negative regulatory events includes CTLA-4, PD-1 and Notch that control T cell signal transduction. These studies deals with the yin/yang of the CD28/CTLA-4 pathways which are essential for a homeostatic T cell response.
- Track 1-1Immunological techniques
- Track 1-2Immune regulation
- Track 1-3Immunological aspects of infection
- Track 1-4Immunological aspects of skin diseases
- Track 1-5Immunological aspects of allergy and anaphylaxis
- Track 1-6Immunology of HIV infections
- Track 1-7Immunological aspects of cardiac diseases
- Track 1-8Immunological aspects of renal diseases
- Track 1-9Immune-mediated neurological syndromes
- Track 1-10Immunological aspects of endocrine diseases
- Track 2-1Natural killer cell immunology
- Track 2-2Diverse immunologic roles of T cells
- Track 2-3Delayed-type hypersensitivity or cellular immunity
- Track 2-4Immunologic deficiency states and their reconstitution
- Track 2-5Immunologic surveillance and tumor immunity
- Track 2-6Immunomodulation
- Track 2-7Nonantibody immunity
- Track 2-8Parasite immunology
- Track 2-9Resistance to intracellular microbial and viral infection
- Track 2-10Thymus and lymphocyte immunobiology
- Track 2-11Transplantation Immunology
- Track 3-1Insights for Immunotherapy
- Track 3-2The intersection of Inflammation, Immunity, and Cancer
- Track 3-3Cancer vaccines:Tumor cell vaccines, antigen vaccines, antigen vaccines, vector-based vaccines:
- Track 3-4Non-specific cancer immunotherapies and adjuvants
- Track 3-5Chimeric antigen receptor (CAR) T-cell therapy
- Track 3-6Tumor-infiltrating lymphocytes and interleukin-2 (IL-2)
- Track 3-7Immunotherapy for Inflammation
- Track 4-1Flu: Current research and future research strategies
- Track 4-2Global dengue: Challenges and promises
- Track 4-3Ebola : Overview and therapeutics
- Track 5-1Biomarkers for disease staging
- Track 5-2Beta cell biology and immune interactions
- Track 5-3Experimental diabetes – Immune responses and therapy
- Track 5-4Immunology of autoantigen-specific strategies and novel agents
- Track 5-5Environmental triggers impacting disease pathogenesis
- Track 5-6Immunometabolism
- Track 5-7Innate immunity and diabetes
- Track 6-1Immune homeostasis: Immunity versus tolerance
- Track 6-2Immune modulation of tumors
- Track 6-3Central nervous system-targeted autoimmunity
- Track 6-4Tissue-specific autoimmunity
- Track 6-5B cell differentiation pathways and disease susceptibility
- Track 6-6Transplant rejection and engraftment
- Track 6-7Next generation immune-based therapies
- Track 7-1Immunoreceptor signalings: Receptors and pathways
- Track 7-2Modeling signaling pathways and transcriptional networks
- Track 7-3Cellular communication, migration and dynamics
- Track 7-4Systems analysis of cancer and model organisms
- Track 7-5Human systems immunology
- Track 8-1Immunological paradox of pregnancy
- Track 8-2Factors involved in trophoblast invasion
- Track 8-3Immune cells and cytokines in implantation
- Track 8-4Mucosal immunity and sexually transmitted infections and Diseases
- Track 8-5Immune-mediated sub-fertility and pregnancy complications
- Track 8-6Immunogenetics in reproduction
- Track 9-1Metabolism, cytokines and immunity
- Track 9-2Targeting cytokines & chemokines for therapeutic interventions
- Track 9-3Advances in innate and adaptive Immunity
- Track 9-4Tumorigenesis and clinical medicine
- Track 9-5Diagnostic and clinical applications
- Track 9-6Cytokines, cancer immunotherapy
- Track 9-7Cytokines and the impact of the microbiome
- Track 9-8Signal transduction
- Track 9-9Embryonic development
- Track 9-10Cell growth and differentiation
- Track 10-1Advancements in vaccine development, novel tools- machinary used
- Track 10-2Sub-unit vaccines: New trends
- Track 10-3Vaccines for pregnant women
- Track 10-4Delivery technologies
- Track 10-5Recent trends in attenuated vaccines
- Track 10-6Next-gen conjugate vaccines
- Track 12-1Clinical trials to prevent and treat food allergy
- Track 12-2Epidemiology and genetics of food allergy and anaphylaxis
- Track 14-1Immunosuppressive agents: Current trends
- Track 14-2Tolerance induction; xenotransplantation; islet cell transplantation
- Track 14-3Anti-donor antibodies and current research
- Track 14-4Potential xenotransplantation
- Track 14-5 Immunocelltherapy (adoptive T cell transfer)
- Track 14-6Immunodermatology
- Track 14-7Biological clock
- Track 16-1 The humoral components of Innate Immunity
- Track 16-2Cell based effector mechanisms
- Track 16-3The Cellular components of Innate Immunity
- Track 16-4 Case Studies
- Track 16-5 Innate immune evasion
- Track 18-1Role in health and disease
- Track 18-2Cutting edge research in nutritional immunology
- Track 18-3Nutrition-inflammation interactions
- Track 18-4Obesity, inflammation and immunity
- Track 18-5Immune profiling in metabolic diseases
- Track 18-6White-brown adipocyte plasticity and inflammation
- Track 18-7Nutrition, immunity and chronic age-related diseases
- Track 18-8Neuroinflammation and ageing
- Track 18-9Early life nutritional influences on the immune system
- Track 18-10Nutrition and immune cell signaling
- Track 18-11Nutrient-gene interactions in the immune system
- Track 18-12The metabolic cost of infection and inflammation
- Track 18-13Nutritional immunologyold challenges & new approaches
- Track 19-1Neuro-immune interaction
- Track 19-2Neurophysiology/Epilepsy
- Track 19-3Autoimmune neuropathies
- Track 19-4Neuroimmunological infectious diseases
- Track 19-5Maternal cytokines in neurodevelopmental disorders
- Track 19-6Neurological disorders
- Track 19-7Neurodegenerative diseases
- Track 19-8Blood brain barrier and diseases
- Track 19-9Neurovirology
- Track 20-1Computational methods for immunogenicity evaluation
- Track 20-2Immunogenicity assessment for peptide therapeutics
- Track 20-3Immunogenicity assessment for biosimilars
- Track 20-4 Immunotoxicity evaluation of novel drug candidates
- Track 20-5Protein aggregation, biological activity & immunogenicity
- Track 22-1Human and animal viral immunology
- Track 22-2Immunological characterization of viral components
- Track 22-3Pathogenic mechanisms
- Track 22-4Virus-based immunological diseases, including autoimmune syndromes
- Track 22-5Research and development of viral vaccines, including field trials
- Track 22-6Viral diagnostics
- Track 22-7Tumor and cancer immunology with virus as the primary factor
- Track 22-8Viral immunology methods
- Track 22-9EBOLA, FLU, HIV ...
- Track 23-1New developments in rheumatology
- Track 23-2Challenges of remote and rural rheumatology
- Track 23-3Pharmacoepidemiology: New Truths, New Lies
- Track 23-4Clinical challenges in gout
- Track 23-5Diagnosis of lupus in the new age of biomarkers:
- Track 23-6Essentials: Disease assessment and managemen
- Track 23-7Drug safety in rheumatology
- Track 24-1Biology of innate and adaptive immune responses at mucosal surfaces
- Track 24-2The host-microbiota interface
- Track 24-3 Impact of the microbiota on systemic immunity
- Track 24-4Mucosal immunity in humans
- Track 24-5Translational immunology in inflammatory bowel disease
- Track 24-6Mechanisms of antigen uptake
- Track 24-7 Regulation of immunity in the intestine, lung and UG tract
- Track 24-8Mucosal co-factors: Infections and diseases
- Track 25-1Lymphocytes: Research and novel strategies
- Track 25-2Antibodies and neuroscience
- Track 25-3Monoclonal antibodies and organ cancers
- Track 25-4Antibodies and infectious diseases
- Track 25-5Antibody biology & engineering
- Track 25-6Antibodies as drugs: Immunological scaffolds as therapeutics
- Track 25-7Antibody-targeted fusion proteins for cancer therapy
- Track 25-8Genetics and epigenetics of the immune system
- Track 25-9Genomic, metabolomic and proteomic advances in cancer immunotherapy
- Track 26-1Immune Response and Bacterial Infections
- Track 26-2Bacterial Toxins and Immnology
- Track 26-3Intracellular Bacterial Vaccine Vectors
- Track 27-1Immune responses to fungal pathogens
- Track 27-2Components of Innate Immunity to Fungi
- Track 27-3Structures and Signals that Impact Fungal Immunity
- Track 27-4Adaptive and Maladaptive Immunity to Fungi
- Track 27-5Host-Fungal Pathogen Interactions: Systems Biology and Beyond
- Track 27-6Intracellular Parasitism
- Track 27-7Harnessing Immunity to Fungi in the Clinic
- Track 28-1Pathogenic and regulatory B cells in autoimmune disease
- Track 28-2Central Nervous System and the Immune System
- Track 28-3Novelties in Autoimmunity
- Track 28-4Epigenetic control of autoimmune diseases
- Track 28-5Autoimmunity in Dermatology
- Track 28-6Cancer and Autoimmunity
- Track 28-7Immunodeficiency diseases
- Track 28-8Balancing immune homeostasis with effector and regulatory T cells
- Track 28-9Breakthrough innovations in understanding pathogenesis of disease
- Track 28-10 Multiple Sclerosis, Myasthenia gravis,Polymyositis, Dermatomyositis, Sarkoidosis,Wegener’s Disease
- Track 28-11Balancing immune homeostasis with effector and regulatory T cells
- Track 28-12Breakthrough innovations in understanding pathogenesis of disease
- Track 28-13Antinuclear antibodies (ANA) immunofluorescence
- Track 28-14Inflammatory Bowel Diseases (IBD) & Gastroenterology
- Track 28-15Cytokine governance of tolerance and inflammation
- Track 28-16Sjögren’s Syndrome, Skleroderma, Progressive systemic Sclerosis, Skleroderma, Progressive systemic Sclerosis
- Track 28-17Dermatomyositis, Colitis Ulcerativa, Crohn´s Disease, Guillain-Barré Syndrome, Lupus Erythematosus (SLE)
- Track 29-1Pulmonology
- Track 29-2Pediatric Allergies
- Track 29-3Asthma
- Track 29-4Hay fever (allergic rhinitis)
- Track 29-5Sinusitis and Frequent sinusitis, pneumonia, or diarrhea
- Track 29-6Eczema (atopic dermatitis)
- Track 29-7Hives (urticaria, welts)
- Track 29-8Severe reactions to foods, insect stings, and medications (anaphylaxis)
- Track 29-9Severe, unusual infections